Ashton Thomas Private Wealth LLC Buys Shares of 2,114 Ulta Beauty, Inc. (NASDAQ:ULTA)

Ashton Thomas Private Wealth LLC bought a new stake in Ulta Beauty, Inc. (NASDAQ:ULTA) in the fourth quarter, HoldingsChannel.com reports. The fund bought 2,114 shares of the specialty retailer’s stock, valued at approximately $919,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of ULTA. Sunbelt Securities Inc. boosted its position in shares of Ulta Beauty by 118.4% during the third quarter. Sunbelt Securities Inc. now owns 83 shares of the specialty retailer’s stock worth $32,000 after buying an additional 45 shares during the period. Westside Investment Management Inc. boosted its position in shares of Ulta Beauty by 151.5% during the third quarter. Westside Investment Management Inc. now owns 83 shares of the specialty retailer’s stock worth $32,000 after buying an additional 50 shares during the period. Edge Capital Group LLC acquired a new position in shares of Ulta Beauty during the fourth quarter worth approximately $33,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Ulta Beauty during the third quarter worth approximately $41,000. Finally, Future Financial Wealth Managment LLC acquired a new position in shares of Ulta Beauty during the fourth quarter worth approximately $43,000. 90.39% of the stock is currently owned by institutional investors and hedge funds.

Ulta Beauty Stock Up 0.1 %

Shares of NASDAQ:ULTA opened at $355.43 on Monday. The company’s fifty day moving average is $394.36 and its two-hundred day moving average is $388.12. Ulta Beauty, Inc. has a 12-month low of $318.17 and a 12-month high of $574.76. The company has a market cap of $16.48 billion, a P/E ratio of 14.22, a price-to-earnings-growth ratio of 0.89 and a beta of 1.34.

Ulta Beauty (NASDAQ:ULTA) last announced its earnings results on Thursday, December 5th. The specialty retailer reported $5.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.45 by $0.69. Ulta Beauty had a net margin of 10.58% and a return on equity of 51.95%. The company had revenue of $2.53 billion for the quarter, compared to the consensus estimate of $2.50 billion. During the same period in the previous year, the business earned $5.07 EPS. The company’s revenue was up 1.7% on a year-over-year basis. Equities research analysts anticipate that Ulta Beauty, Inc. will post 23.96 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ULTA shares. B. Riley upgraded Ulta Beauty from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $330.00 to $430.00 in a research report on Tuesday, January 7th. TD Cowen upped their target price on Ulta Beauty from $450.00 to $480.00 and gave the stock a “hold” rating in a research report on Wednesday, January 8th. Bank of America upped their target price on Ulta Beauty from $460.00 to $475.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 7th. DA Davidson upped their target price on Ulta Beauty from $435.00 to $510.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Finally, Wells Fargo & Company upped their target price on Ulta Beauty from $350.00 to $370.00 and gave the stock an “underweight” rating in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $459.22.

About Ulta Beauty

Ulta Beauty, Inc operates as a specialty beauty retailer in the United States. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications.